Enovis CORP (ENOV) stock
Close on Nov 18, 2026Market cap $1.56BP/E –Yield –
Earnings
Enovis's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Enovis's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Feb 25, 2027Expected | – | – | – | – | – |
| Q3 FY2026ended Oct 2, 2026 | Nov 5, 2026before the open | $559.00M | +1.8% | $0.02 | $0.88 | Release |
| Q2 FY2026ended Jul 3, 2026 | Aug 6, 2026before the open | $583.00M | +3.2% | -$0.02 | $0.90 | Release |
| Q1 FY2026ended Apr 3, 2026 | May 7, 2026before the open | $589.00M | +5.4% | -$0.15 | $0.89 | Release |
| Q4 FY2025ended Dec 31, 2025 | Feb 26, 2026before the open | $576.00M | +2.7% | -$9.07 | $0.95 | Release |
| Q3 FY2025ended Oct 3, 2025 | Nov 6, 2025before the open | $549.00M | +8.7% | -$9.99 | $0.75 | Release |
| Q2 FY2025ended Jul 4, 2025 | Aug 7, 2025before the open | $565.00M | +7.6% | -$0.64 | $0.79 | Release |
| Q1 FY2025ended Apr 4, 2025 | May 8, 2025before the open | $559.00M | +8.3% | -$0.98 | $0.81 | Release |
| Q4 FY2024ended Dec 31, 2024 | Feb 26, 2025before the open | $561.00M | +23.3% | -$12.06 | $0.98 | Release |
| Q3 FY2024ended Sep 27, 2024 | Nov 6, 2024before the open | $505.00M | +20.8% | -$0.61 | $0.73 | Release |
| Q2 FY2024ended Jun 28, 2024 | Aug 7, 2024before the open | $525.00M | +22.4% | -$0.34 | $0.62 | Release |
| Q1 FY2024ended Mar 29, 2024 | May 2, 2024before the open | $516.00M | +27.1% | -$1.32 | $0.50 | Release |
| Q4 FY2023ended Dec 31, 2023 | Feb 22, 2024before the open | $455.00M | +11.2% | $0.05 | $0.79 | Release |
| Q3 FY2023ended Sep 29, 2023 | Nov 7, 2023before the open | $418.00M | +8.9% | -$0.36 | $0.56 | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 3, 2023before the open | $429.00M | +8.6% | -$0.27 | $0.61 | Release |
| Q1 FY2023ended Mar 31, 2023 | May 4, 2023before the open | $406.00M | – | -$0.42 | $0.44 | Release |
| Q4 FY2022ended Dec 31, 2022 | Feb 23, 2023before the open | $409.00M | -60.0% | -$0.71 | $0.72 | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 2, 2022before the open | $384.00M | -60.2% | -$1.22 | $0.59 | Release |
| Q2 FY2022ended Jul 1, 2022 | Aug 4, 2022before the open | $395.00M | – | $2.21 | $0.59 | Release |
| Q4 FY2021ended Dec 31, 2021 | Feb 22, 2022before the open | $1.02B | – | $0.06 | $0.59 | Release |
| Q3 FY2021ended Oct 1, 2021 | Nov 4, 2021before the open | $966.00M | – | $0.17 | $0.54 | Release |
| Q2 FY2021ended Jul 2, 2021 | Jul 28, 2021after the close | – | – | – | – | Filing |
| Q1 FY2021ended Apr 2, 2021 | Apr 29, 2021before the open | – | – | – | – | Filing |
| Q4 FY2020ended Dec 31, 2020 | Feb 18, 2021before the open | – | – | – | – | Filing |
| Q3 FY2020ended Oct 2, 2020 | Oct 29, 2020before the open | – | – | – | – | Filing |
| Q2 FY2020ended Jul 3, 2020 | Aug 6, 2020before the open | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Enovis's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| organic revenue growthnon-GAAP | FY2026 | +5% | – | New | Nov 5, 2026 |
| organic revenue growth | FY2026 | +4% – +6% | +4% – +6% | Reaffirmed | Aug 6, 2026 |
| organic revenue growthnon-GAAP | FY2026 | +4% – +6% | – | New | Feb 26, 2026 |
| Revenue | FY2026 | $2.31B – $2.37B | $2.31B – $2.37B | Reaffirmed | Aug 6, 2026 |
| Revenue guidanceGAAP | FY2026 | $2.32B – $2.35B | – | New | Nov 5, 2026 |
| Adjusted EBITDAnon-GAAP | FY2026 | $425.00M – $435.00M | $425.00M – $435.00M | Reaffirmed | Aug 6, 2026 |
| Adjusted EBITDA guidancenon-GAAP | FY2026 | $428.00M – $438.00M | – | New | Nov 5, 2026 |
| adjusted earnings per sharenon-GAAP | FY2026 | $3.52 – $3.73 | $3.52 – $3.73 | Reaffirmed | Aug 6, 2026 |
| Full-year adjusted earnings per share guidancenon-GAAP | FY2026 | $3.58 – $3.79 | – | New | Nov 5, 2026 |
| free cash flow conversion | FY2026 | 25% | – | New | Aug 6, 2026 |
| free cash flow conversionnon-GAAP | FY2026 | 25% | – | New | May 7, 2026 |
Guidance vs results
The last range Enovis gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| FY2025 | adjusted earnings per share | $3.10 – $3.25 | $3.30Σ4Q | Above range |
| FY2025 | Revenue | $2.24B – $2.27B | $2.25BΣ4Q | Within range |
Guidance history
Every forecast Enovis put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Nov 5, 2026 | Adjusted EBITDA guidance | FY2026 | $428.00M – $438.00M | New |
| Nov 5, 2026 | Full-year adjusted earnings per share guidance | FY2026 | $3.58 – $3.79 | New |
| Nov 5, 2026 | Revenue guidance | FY2026 | $2.32B – $2.35B | New |
| Nov 5, 2026 | organic revenue growth | FY2026 | +5% | New |
| Aug 6, 2026 | Adjusted EBITDA | FY2026 | $425.00M – $435.00M | Reaffirmed |
| Aug 6, 2026 | adjusted earnings per share | FY2026 | $3.52 – $3.73 | Reaffirmed |
| Aug 6, 2026 | free cash flow conversion | FY2026 | 25% | New |
| Aug 6, 2026 | organic revenue growth | FY2026 | +4% – +6% | Reaffirmed |
| Aug 6, 2026 | Revenue | FY2026 | $2.31B – $2.37B | Reaffirmed |
| May 7, 2026 | Adjusted EBITDA | FY2026 | $425.00M – $435.00M | Reaffirmed |
| May 7, 2026 | adjusted earnings per share | FY2026 | $3.52 – $3.73 | Reaffirmed |
| May 7, 2026 | free cash flow conversion | FY2026 | 25% | New |
| May 7, 2026 | Revenue | FY2026 | $2.31B – $2.37B | Reaffirmed |
| May 7, 2026 | organic revenue growth | FY2026 | +4% – +6% | New |
| Feb 26, 2026 | Adjusted EBITDA | FY2026 | $425.00M – $435.00M | New |
| Feb 26, 2026 | adjusted earnings per share | FY2026 | $3.52 – $3.73 | New |
| Feb 26, 2026 | Revenue | FY2026 | $2.31B – $2.37B | New |
| Feb 26, 2026 | organic revenue growth | FY2026 | +4% – +6% | New |
| Nov 6, 2025 | Adjusted EBITDA | FY2025 | $395.00M – $405.00M | New |
| Nov 6, 2025 | adjusted earnings per share | FY2025 | $3.10 – $3.25 | New |
| Nov 6, 2025 | Revenue | FY2025 | $2.24B – $2.27B | New |
| Aug 7, 2025 | Adjusted EBITDA | FY2025 | $392.00M – $402.00M | Raised |
| Aug 7, 2025 | adjusted earnings per share | FY2025 | $3.05 – $3.20 | Raised |
| Aug 7, 2025 | Revenue | FY2025 | $2.25B – $2.28B | Raised |
| May 8, 2025 | Adjusted EBITDA | FY2025 | $385.00M – $395.00M | Lowered |
| May 8, 2025 | adjusted earnings per share | FY2025 | $2.95 – $3.10 | Lowered |
| May 8, 2025 | Revenue | FY2025 | $2.22B – $2.25B | Raised |
| Feb 26, 2025 | Adjusted EBITDA | FY2025 | $405.00M – $415.00M | New |
| Feb 26, 2025 | Full-year adjusted earnings per share | FY2025 | $3.10 – $3.25 | New |
| Feb 26, 2025 | organic revenue growth | FY2025 | +6% – +6.5% | New |
| Feb 26, 2025 | Revenue | FY2025 | $2.19B – $2.22B | New |
| Nov 6, 2024 | adjusted EBITDA | FY2024 | $373.00M – $378.00M | Narrowed |
| Nov 6, 2024 | adjusted earnings per diluted share | FY2024 | $2.75 – $2.80 | Raised |
| Nov 6, 2024 | Full-year revenue | FY2024 | $2.10B | Narrowed |
| Aug 7, 2024 | adjusted EBITDA | FY2024 | $368.00M – $383.00M | Reaffirmed |
| Aug 7, 2024 | adjusted earnings per diluted share | FY2024 | $2.62 – $2.77 | Raised |
| Aug 7, 2024 | revenue | FY2024 | $2.08B – $2.13B | Narrowed |
| May 2, 2024 | adjusted EBITDA | FY2024 | $368.00M – $383.00M | Raised |
| May 2, 2024 | adjusted earnings per diluted share | FY2024 | $2.52 – $2.67 | Raised |
| May 2, 2024 | revenue | FY2024 | $2.06B – $2.16B | New |
| Feb 22, 2024 | Adjusted EBITDA | FY2024 | $365.00M – $380.00M | New |
| Feb 22, 2024 | adjusted earnings per diluted share | FY2024 | $2.50 – $2.65 | New |
| Feb 22, 2024 | Revenue | FY2024 | $2.05B – $2.15B | New |
| Nov 7, 2023 | adjusted EBITDA | FY2023 | $264.00M – $270.00M | Raised |
| Nov 7, 2023 | full-year adjusted earnings per diluted share | FY2023 | $2.30 – $2.40 | Raised |
| Nov 7, 2023 | Revenue | FY2023 | +7.4% – +7.6% | Raised |
| Aug 3, 2023 | adjusted EBITDA | FY2023 | $262.00M – $270.00M | Raised |
| Aug 3, 2023 | adjusted earnings per diluted share | FY2023 | $2.22 – $2.36 | Raised |
| Aug 3, 2023 | Revenue | FY2023 | +7% – +7.5% | Raised |
| May 4, 2023 | adjusted EBITDA | FY2023 | $259.00M – $267.00M | Raised |
| May 4, 2023 | Adjusted earnings per diluted share | FY2023 | $2.18 – $2.32 | Raised |
| May 4, 2023 | Revenue | FY2023 | +6% – +7% | Raised |
| Feb 23, 2023 | adjusted EBITDA | FY2023 | $255.00M – $265.00M | New |
| Feb 23, 2023 | adjusted earnings per diluted share | FY2023 | $2.15 – $2.30 | New |
| Feb 23, 2023 | Revenue | FY2023 | +5% – +6% | New |
| Nov 2, 2022 | adjusted EBITDA | FY2022 | $235.00M – $240.00M | Lowered |
| Nov 2, 2022 | adjusted earnings per share | FY2022 | $2.20 – $2.25 | Narrowed |
| Nov 2, 2022 | total sales growth | FY2022 | +10% | New |
| Nov 2, 2022 | organic growth | FY2022 | +6.5% | Narrowed |
| Aug 4, 2022 | adjusted EBITDA | FY2022 | $235.00M – $255.00M | Lowered |
| Aug 4, 2022 | adjusted EPS | FY2022 | $2.15 – $2.35 | New |
| Aug 4, 2022 | organic growth | FY2022 | +6% – +9% | Lowered |
| Feb 22, 2022 | segment-level adjusted EBITDA | FY2022 | $455.00M – $475.00M | Raised |
| Feb 22, 2022 | segment-level adjusted EBITDA | FY2022 | $280.00M – $300.00M | New |
| Feb 22, 2022 | sales | FY2022 | +10% – +14% | New |
| Feb 22, 2022 | organic sales growth | FY2022 | +7% – +10% | Raised |
| Feb 22, 2022 | organic growth | FY2022 | +6% – +9% | New |
| Nov 4, 2021 | adjusted EPS | FY2021 | $2.10 – $2.20 | New |
| Nov 4, 2021 | free cash flow | FY2021 | $275.00M | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Enovis filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Update
- Update
- Results
- Results
- Results
- Update
- Results
- Results
- Results
- Update
- Results
- Update
- Update
- Results
See a number that looks wrong?